Home › Funds › PNC Financial Services › AMRX
PNC Financial Services position in AMRX
AMNEAL PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)2.02K sh
Reported value held$34.91K
Portfolio Weight0.00%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 200 | $1.00K | New |
| Q1 2022 | 200 | $1.00K | Hold |
| Q2 2022 | 200 | $1.00K | Hold |
| Q3 2022 | 200 | $0 | Hold |
| Q4 2022 | 200 | $398 | Hold |
| Q1 2023 | 200 | $278 | Hold |
| Q2 2023 | 333 | $1.03K | Add |
| Q3 2023 | 133 | $561 | Reduce |
| Q4 2023 | 230 | $1.40K | Add |
| Q1 2024 | 504 | $3.05K | Add |
| Q2 2024 | 472 | $3.00K | Reduce |
| Q3 2024 | 472 | $3.93K | Hold |
| Q4 2024 | 435 | $3.44K | Reduce |
| Q1 2025 | 448 | $3.75K | Add |
| Q2 2025 | 529 | $4.28K | Add |
| Q3 2025 | 499 | $5.00K | Reduce |
| Q4 2025 | 512 | $6.45K | Add |
| Q1 2026 | 1.73K | $21.53K | Add |
| Q2 2026 | 2.02K | $34.91K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding AMRX
- BlackRock Inc 26.56M sh · $459.79M · Q2 2026
- Vanguard Group 17.91M sh · $225.64M · Q4 2025
- Geode Capital Management 5.14M sh · $88.98M · Q2 2026
- Morgan Stanley 4.11M sh · $71.14M · Q2 2026
- Invesco Ltd 3.50M sh · $60.62M · Q2 2026
- Goldman Sachs Group 3.01M sh · $52.17M · Q2 2026
- Charles Schwab Investment Management 2.15M sh · $37.17M · Q2 2026
- Northern Trust Corp 1.91M sh · $33.15M · Q2 2026
- Citadel Advisors 1.15M sh · $19.87M · Q2 2026
- BNY Mellon 1.02M sh · $17.57M · Q2 2026
- Principal Global Investors 991.82K sh · $17.17M · Q2 2026
- Fidelity Management & Research (FMR) 825.12K sh · $14.28M · Q2 2026